These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30982688)

  • 1. SABR-COMET: harbinger of a new cancer treatment paradigm.
    Loo BW; Diehn M
    Lancet; 2019 May; 393(10185):2013-2014. PubMed ID: 30982688
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.
    Boujelbene N; Elloumi F; Kamel ME; Abeidi H; Matzinger O; Mirimanoff RO; Khanfir K
    Swiss Med Wkly; 2013; 143():w13780. PubMed ID: 23740331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SABR improves outcomes.
    Romero D
    Nat Rev Clin Oncol; 2019 Jul; 16(7):402. PubMed ID: 31024080
    [No Abstract]   [Full Text] [Related]  

  • 4. SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer.
    Westover KD; Iyengar P; Sharma AN; Timmerman R
    Lung Cancer; 2015 Aug; 89(2):87-93. PubMed ID: 26028304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise.
    Kamrava M; Chino JP; Beriwal S
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):472-474. PubMed ID: 32014146
    [No Abstract]   [Full Text] [Related]  

  • 6. SABR versus conventional fractionation regimens in NSCLC.
    Addeo A; Buffoni L
    Lancet Oncol; 2019 May; 20(5):e230. PubMed ID: 31044707
    [No Abstract]   [Full Text] [Related]  

  • 7. SABR versus conventional fractionation regimens in NSCLC.
    Joseph N; Choudhury A
    Lancet Oncol; 2019 May; 20(5):e231. PubMed ID: 31044708
    [No Abstract]   [Full Text] [Related]  

  • 8. SABR Given Thoughtfully.
    Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):766. PubMed ID: 29063843
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
    Iyengar P; Westover K; Timmerman RD
    Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Stage I Lung Cancer with Stereotactic Ablative Radiation Therapy.
    Dan T; Williams NL
    Surg Oncol Clin N Am; 2017 Jul; 26(3):393-403. PubMed ID: 28576179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SABR versus conventional fractionation regimens in NSCLC - Authors' reply.
    Ball D; Herschtal A
    Lancet Oncol; 2019 May; 20(5):e232. PubMed ID: 31044709
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.
    Soldà F; Lodge M; Ashley S; Whitington A; Goldstraw P; Brada M
    Radiother Oncol; 2013 Oct; 109(1):1-7. PubMed ID: 24128806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SABR in NSCLC--the beginning of the end or the end of the beginning?
    Brada M; Pope A; Baumann M
    Radiother Oncol; 2015 Feb; 114(2):135-7. PubMed ID: 25665955
    [No Abstract]   [Full Text] [Related]  

  • 14. CyberKnife stereotactic ablative radiotherapy for lung tumors.
    Gibbs IC; Loo BW
    Technol Cancer Res Treat; 2010 Dec; 9(6):589-96. PubMed ID: 21070081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
    Abbas G; Danish A; Krasna MJ
    Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live to SABR Another Day?
    Tran PT; Feng F; Ost P
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1097. PubMed ID: 29722652
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non-Small-Cell Lung Cancer: CEPO Review and Recommendations.
    Boily G; Filion É; Rakovich G; Kopek N; Tremblay L; Samson B; Goulet S; Roy I;
    J Thorac Oncol; 2015 Jun; 10(6):872-82. PubMed ID: 26001140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer.
    Shultz DB; Diehn M; Loo BW
    Semin Radiat Oncol; 2015 Apr; 25(2):78-86. PubMed ID: 25771411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The optimal treatment of stage I nonsmall cell lung cancer in the era of SABR and modern day lung resections.
    Vallieres E
    Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 33184101
    [No Abstract]   [Full Text] [Related]  

  • 20. SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?
    Chen H; Louie AV
    Curr Treat Options Oncol; 2016 Jun; 17(6):27. PubMed ID: 27098533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.